Biphasic skin reactions during telaprevir-based therapy of Japanese patients infected with hepatitis C virus Akiko Kishi, MD, Nobukazu Hayashi, MD, PhD, Kuniaki Ohara, MD, Keiji Aoki, MSc, Ichimaro Yamada, PhD, Kenji Ikeda, MD, PhD, Hiromitsu Kumada, MD, PhD Journal of the American Academy of Dermatology Volume 70, Issue 3, Pages 584-586 (March 2014) DOI: 10.1016/j.jaad.2013.11.003 Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Time of onset of drug eruptions during administration of telaprevir-based triple therapy for hepatitis C. EPRs, Early-phase reactions; LPRs, late-phase reactions. Journal of the American Academy of Dermatology 2014 70, 584-586DOI: (10.1016/j.jaad.2013.11.003) Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 Comparison of early- and late-phase skin reactions in telaprevir-based triple therapy for hepatitis C. A, Skin reaction during the early phase (onset day: day 3, date of photo: day 4). B, Skin reaction during the late phase (onset day: day 31, date of photo: day 53). Journal of the American Academy of Dermatology 2014 70, 584-586DOI: (10.1016/j.jaad.2013.11.003) Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions